Abstract
The development of new drugs is becoming notably harder each decade. To overcome the present pitfalls in the drug development pipeline, such as those related to potency, selectivity, or absorption, distribution, metabolism, excretion and toxicity properties, medicinal chemistry strategies need to be in continuous evolution and need to become even more multidisciplinary. In this review, we present how structure-based, ligand-based, and fragment-based drug design (SBDD, LBDD, and FBDD, respectively) and their respective techniques were used for the design and optimization of successful cases of New Molecular Entities (NMEs) approved by the Food and Drug Administration (FDA).
Keywords: Drug design, medicinal chemistry, new molecular entities, FDA-approved drugs, structure-based drug design, SBDD, ligand-based drug design, LBDD, fragment-based drug design, FBDD.
Mini-Reviews in Medicinal Chemistry
Title:Insights into Newly Approved Drugs from a Medicinal Chemistry Perspective
Volume: 21 Issue: 16
Author(s): Elys Juliane Cardoso Lima, Renan Augusto Gomes, Evelin Fornari, Flavio da Silva Emery and Gustavo Henrique Goulart Trossini*
Affiliation:
- Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo,Brazil
Keywords: Drug design, medicinal chemistry, new molecular entities, FDA-approved drugs, structure-based drug design, SBDD, ligand-based drug design, LBDD, fragment-based drug design, FBDD.
Abstract: The development of new drugs is becoming notably harder each decade. To overcome the present pitfalls in the drug development pipeline, such as those related to potency, selectivity, or absorption, distribution, metabolism, excretion and toxicity properties, medicinal chemistry strategies need to be in continuous evolution and need to become even more multidisciplinary. In this review, we present how structure-based, ligand-based, and fragment-based drug design (SBDD, LBDD, and FBDD, respectively) and their respective techniques were used for the design and optimization of successful cases of New Molecular Entities (NMEs) approved by the Food and Drug Administration (FDA).
Export Options
About this article
Cite this article as:
Lima Juliane Cardoso Elys , Gomes Augusto Renan , Fornari Evelin, da Silva Emery Flavio and Trossini Henrique Goulart Gustavo *, Insights into Newly Approved Drugs from a Medicinal Chemistry Perspective, Mini-Reviews in Medicinal Chemistry 2021; 21 (16) . https://dx.doi.org/10.2174/1389557521666210226145328
DOI https://dx.doi.org/10.2174/1389557521666210226145328 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Drugs and mitochondria
Mitochondria play a central role in the life and death of cells. They are not merely the center for energy metabolism but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signaling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer’s, Parkinson’s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Elucidation and Therapeutic Targeting for CombatingCOVID-19: Current Scenario and Future Prospective
Current Molecular Medicine IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine
Current Pharmaceutical Design Design and Development of a Novel Supportive Care Product for the Treatment of Sialorrhea in Parkinson’s Disease
Current Topics in Medicinal Chemistry Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan – How to Do it Yourself!
Current Topics in Medicinal Chemistry The 21st Century Form of Vitamin E - Tocotrienol
Current Pharmaceutical Design Glycosides from Medicinal Plants as Potential Anticancer Agents: Emerging Trends Towards Future Drugs
Current Medicinal Chemistry HDL Elevation and Lipid Lowering Therapy: Current Scenario and Future Perspectives
Recent Patents on Cardiovascular Drug Discovery Macrocyclic Histone Deacetylase Inhibitors
Current Topics in Medicinal Chemistry Endocannabinoids as Regulators of Transient Receptor Potential (TRP)Channels: a Further Opportunity to Develop New Endocannabinoid-Based Therapeutic Drugs
Current Medicinal Chemistry Design of Novel Phosphopantetheine Adenylyltransferase Inhibitors: A Potential New Approach to Tackle <i>Mycobacterium tuberculosis</i>
Current Topics in Medicinal Chemistry Nanomedicine: Magnetic Nanoparticles and their Biomedical Applications
Current Medicinal Chemistry Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy
Current Cancer Drug Targets Glycoconjugates of Quinolines: Application in Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness:Mechanisms and Future Outlook
Current Pharmaceutical Design Microwave Syntheses: A Modern Day Approach Towards Sustainable Chemistry
Current Microwave Chemistry Smartphone Addiction among Students and its Harmful Effects on MentalHealth, Oxidative Stress, and Neurodegeneration towards FutureModulation of Anti-Addiction Therapies: A Comprehensive Survey basedon SLR, Research Questions, and Network Visualization Techniques
CNS & Neurological Disorders - Drug Targets Multidisciplinary Study on Immigrants African and Asian Children’s Health: Socio-Cultural Factors Influencing Breastfeeding
Current Women`s Health Reviews Structure Activity Relationship Study and Recent Advances in the Design and Synthesis about Linear Antimicrobial Peptides
Current Medicinal Chemistry - Anti-Infective Agents Neurological Effects of SARS-CoV-2 and Neurotoxicity of Antiviral DrugsAgainst COVID-19
Mini-Reviews in Medicinal Chemistry The Recent Development of Tetrahydro-Quinoline/Isoquinoline Based Compounds as Anticancer Agents
Current Topics in Medicinal Chemistry